News

Submitted proposals - World Leading Data and Computing Technologies 2021 - deadline 21/10/2021

Published on | 3 years ago

Programmes Digital, Industry & Space

A total of 109 proposals has been submitted to call HORIZON-CL4-2021-DATA-01, which closed on 21 October 2021.

These proposals, of which the evaluation will be organized over the coming weeks and months, were submitted to the following topics:

  • HORIZON-CL4-2021-DATA-01-01 - Technologies and solutions for compliance, privacy preservation, green and responsible data operations (AI, Data and Robotics Partnership) (RIA): 21 proposals (indicative budget 52 EUR million)
  • HORIZON-CL4-2021-DATA-01-03 - Technologies for data management (IA): 25 proposals (indicative budget 30 EUR million)
  • HORIZON-CL4-2021-DATA-01-05 - Future European platforms for the Edge: Meta Operating Systems (RIA): 55 proposals (indicative budget 54 EUR million)
  • HORIZON-CL4-2021-DATA-01-07 - Coordination and Support of the ‘Cloud-Edge-IoT’ domain (CSA): 7 proposals (indicative budget 3 EUR million)
  • HORIZON-CL4-2021-DATA-01-08 - Roadmap for next generation computing and systems technologies (CSA): 1 proposal (indicative budget 2 EUR million)

Source: Funding and Tender Portal

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1651 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.